We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Boston Scientific Corporation | NYSE:BSX | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.7091 | 0.98% | 73.2591 | 73.415 | 72.62 | 72.70 | 1,789,018 | 18:15:34 |
By Colin Kellaher
Boston Scientific Corp. on Tuesday said it agreed to buy the 84% of Devoro Medical Inc. it doesn't already own for $269 million and up to $67 million in potential clinical and regulatory milestone payments.
The Marlborough, Mass., maker of medical devices, which has been an investor in Devoro since 2019, said the acquisition adds the WOLF Thrombectomy platform to its peripheral interventions portfolio.
The company said it expects to complete the acquisition by the end of the year.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
September 21, 2021 07:30 ET (11:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Boston Scientific Chart |
1 Month Boston Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions